NO20023526L - Kalsium-dikarboksylatetere, fremgangsmåter for fremstilling derav, og behandling av vaskul¶r sykdom og diabetes - Google Patents

Kalsium-dikarboksylatetere, fremgangsmåter for fremstilling derav, og behandling av vaskul¶r sykdom og diabetes

Info

Publication number: NO20023526L
Authority: NO; Norway
Prior art keywords: diabetes; preparation; treatment; methods; vascular disease
Prior art date: 2000-01-25

Application number

NO20023526A

Other languages

English (en)

Norwegian (no)

Other versions

NO20023526D0 (no

Inventor

Howard Yoshihisa Ando

Donald Eugene Butler

Gary Jay Dozeman

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-25

Filing date

2002-07-24

Publication date

2002-08-27

2002-07-24 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2002-07-24 Publication of NO20023526D0 publication Critical patent/NO20023526D0/no

2002-08-27 Publication of NO20023526L publication Critical patent/NO20023526L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Obesity (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

NO20023526A 2000-01-25 2002-07-24 Kalsium-dikarboksylatetere, fremgangsmåter for fremstilling derav, og behandling av vaskul¶r sykdom og diabetes NO20023526L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US17782300P	2000-01-25	2000-01-25
PCT/IB2001/000026 WO2001055078A1 (en)	2000-01-25	2001-01-11	Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith

Publications (2)

Publication Number	Publication Date
NO20023526D0 NO20023526D0 (no)	2002-07-24
NO20023526L true NO20023526L (no)	2002-08-27

Family

ID=22650106

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20023526A NO20023526L (no)	2000-01-25	2002-07-24	Kalsium-dikarboksylatetere, fremgangsmåter for fremstilling derav, og behandling av vaskul¶r sykdom og diabetes

Country Status (39)

Country	Link
EP (1)	EP1259474B1 (xx)
JP (1)	JP4750995B2 (xx)
KR (1)	KR20020073182A (xx)
CN (1)	CN1395555A (xx)
AP (1)	AP2002002587A0 (xx)
AR (1)	AR029436A1 (xx)
AT (1)	ATE431326T1 (xx)
AU (1)	AU2214001A (xx)
BG (1)	BG106851A (xx)
BR (1)	BR0107763A (xx)
CA (1)	CA2397960C (xx)
CO (1)	CO5261537A1 (xx)
CZ (1)	CZ20022474A3 (xx)
DE (1)	DE60138686D1 (xx)
DK (1)	DK1259474T3 (xx)
DZ (1)	DZ3239A1 (xx)
EA (1)	EA004862B1 (xx)
EE (1)	EE200200404A (xx)
ES (1)	ES2324281T3 (xx)
GE (1)	GEP20053428B (xx)
GT (1)	GT200100015A (xx)
HN (1)	HN2001000011A (xx)
HU (1)	HUP0204422A3 (xx)
IL (1)	IL150541A0 (xx)
IS (1)	IS6442A (xx)
MA (1)	MA26867A1 (xx)
MX (1)	MXPA02007223A (xx)
NO (1)	NO20023526L (xx)
NZ (1)	NZ519550A (xx)
OA (1)	OA12166A (xx)
PA (1)	PA8510601A1 (xx)
PE (1)	PE20011064A1 (xx)
PL (1)	PL357076A1 (xx)
SK (1)	SK10622002A3 (xx)
SV (1)	SV2002000290A (xx)
TN (1)	TNSN01013A1 (xx)
UY (1)	UY26550A1 (xx)
WO (1)	WO2001055078A1 (xx)
ZA (1)	ZA200205880B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI1045691T1 (en) *	1997-12-12	2005-04-30	Warner-Lambert Company Llc	Statin-carboxyalkylether combinations
EP1539127A1 (en) *	2002-08-22	2005-06-15	Warner-Lambert Company Llc	Method of treating osteoarthritis
KR20080007315A (ko) *	2005-04-19	2008-01-18	에자이 알앤드디 매니지먼트 가부시키가이샤	비스[(2ｓ)-3-[3-[(2ｓ)-3-(4-클로로-2-시아노페녹시)-2-플루오로프로폭시]페닐]-2-이소프로폭시프로피온산]칼슘 및그 중간체
US7816405B2 (en)	2005-04-19	2010-10-19	Eisai R&D Management Co., Ltd.	Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof
HK1244265A1 (zh) *	2014-11-14	2018-09-14	Gemphire Therapeutics Inc.	用於制备 -二羧酸封端的二烷醚的方法和中间体
WO2018195163A1 (en) *	2017-04-18	2018-10-25	Gemphire Therapeutics Inc.	Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use therefor
US20200253877A1 (en) *	2018-10-18	2020-08-13	Neurobo Pharmaceuticals, Inc.	Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use therefor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5648387A (en)	1995-03-24	1997-07-15	Warner-Lambert Company	Carboxyalkylethers, formulations, and treatment of vascular diseases
NZ503982A (en)	1997-12-12	2002-03-28	Warner Lambert Co	Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

2001
- 2001-01-11 JP JP2001555021A patent/JP4750995B2/ja not_active Expired - Fee Related
- 2001-01-11 CN CN01804045A patent/CN1395555A/zh active Pending
- 2001-01-11 SK SK1062-2002A patent/SK10622002A3/sk not_active Application Discontinuation
- 2001-01-11 DE DE60138686T patent/DE60138686D1/de not_active Expired - Lifetime
- 2001-01-11 WO PCT/IB2001/000026 patent/WO2001055078A1/en not_active Ceased
- 2001-01-11 AU AU22140/01A patent/AU2214001A/en not_active Abandoned
- 2001-01-11 MX MXPA02007223A patent/MXPA02007223A/es active IP Right Grant
- 2001-01-11 KR KR1020027009519A patent/KR20020073182A/ko not_active Ceased
- 2001-01-11 EP EP01900037A patent/EP1259474B1/en not_active Expired - Lifetime
- 2001-01-11 AT AT01900037T patent/ATE431326T1/de not_active IP Right Cessation
- 2001-01-11 NZ NZ519550A patent/NZ519550A/en unknown
- 2001-01-11 IL IL15054101A patent/IL150541A0/xx unknown
- 2001-01-11 HU HU0204422A patent/HUP0204422A3/hu unknown
- 2001-01-11 BR BR0107763-5A patent/BR0107763A/pt not_active IP Right Cessation
- 2001-01-11 DK DK01900037T patent/DK1259474T3/da active
- 2001-01-11 CZ CZ20022474A patent/CZ20022474A3/cs unknown
- 2001-01-11 EE EEP200200404A patent/EE200200404A/xx unknown
- 2001-01-11 DZ DZ013239A patent/DZ3239A1/fr active
- 2001-01-11 CA CA002397960A patent/CA2397960C/en not_active Expired - Lifetime
- 2001-01-11 EA EA200200641A patent/EA004862B1/ru not_active IP Right Cessation
- 2001-01-11 AP APAP/P/2002/002587A patent/AP2002002587A0/en unknown
- 2001-01-11 GE GE4872A patent/GEP20053428B/en unknown
- 2001-01-11 PL PL01357076A patent/PL357076A1/xx not_active Application Discontinuation
- 2001-01-11 ES ES01900037T patent/ES2324281T3/es not_active Expired - Lifetime
- 2001-01-11 OA OA1200200226A patent/OA12166A/en unknown
- 2001-01-22 UY UY26550A patent/UY26550A1/es not_active Application Discontinuation
- 2001-01-22 SV SV2001000290A patent/SV2002000290A/es not_active Application Discontinuation
- 2001-01-23 PA PA20018510601A patent/PA8510601A1/es unknown
- 2001-01-23 GT GT200100015A patent/GT200100015A/es unknown
- 2001-01-23 AR ARP010100284A patent/AR029436A1/es unknown
- 2001-01-24 PE PE2001000076A patent/PE20011064A1/es not_active Application Discontinuation
- 2001-01-24 TN TNTNSN01013A patent/TNSN01013A1/fr unknown
- 2001-01-24 CO CO01005267A patent/CO5261537A1/es not_active Application Discontinuation
- 2001-01-24 HN HN2001000011A patent/HN2001000011A/es unknown
2002
- 2002-06-20 BG BG106851A patent/BG106851A/xx unknown
- 2002-06-25 IS IS6442A patent/IS6442A/is unknown
- 2002-07-22 MA MA26735A patent/MA26867A1/fr unknown
- 2002-07-23 ZA ZA200205880A patent/ZA200205880B/xx unknown
- 2002-07-24 NO NO20023526A patent/NO20023526L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ES2324281T3 (es)	2009-08-04
SK10622002A3 (sk)	2003-07-01
HUP0204422A3 (en)	2003-08-28
BR0107763A (pt)	2002-11-12
DK1259474T3 (da)	2009-07-20
GT200100015A (es)	2001-10-19
SV2002000290A (es)	2002-07-16
AP2002002587A0 (en)	2002-09-30
JP4750995B2 (ja)	2011-08-17
CN1395555A (zh)	2003-02-05
AU2214001A (en)	2001-08-07
CZ20022474A3 (cs)	2003-06-18
GEP20053428B (en)	2005-01-25
PL357076A1 (en)	2004-07-12
UY26550A1 (es)	2001-08-27
EA200200641A1 (ru)	2002-12-26
EA004862B1 (ru)	2004-08-26
TNSN01013A1 (fr)	2005-11-10
ATE431326T1 (de)	2009-05-15
PE20011064A1 (es)	2001-10-22
EE200200404A (et)	2003-10-15
IL150541A0 (en)	2003-02-12
DE60138686D1 (de)	2009-06-25
JP2003520835A (ja)	2003-07-08
CO5261537A1 (es)	2003-03-31
IS6442A (is)	2002-06-25
NZ519550A (en)	2003-11-28
AR029436A1 (es)	2003-06-25
OA12166A (en)	2003-11-07
WO2001055078A1 (en)	2001-08-02
EP1259474A1 (en)	2002-11-27
CA2397960A1 (en)	2001-08-02
MA26867A1 (fr)	2004-12-20
NO20023526D0 (no)	2002-07-24
DZ3239A1 (fr)	2001-08-02
BG106851A (en)	2003-01-31
HN2001000011A (es)	2001-06-13
HUP0204422A2 (en)	2003-05-28
EP1259474B1 (en)	2009-05-13
KR20020073182A (ko)	2002-09-19
ZA200205880B (en)	2003-07-23
PA8510601A1 (es)	2002-08-26
CA2397960C (en)	2008-09-09
MXPA02007223A (es)	2002-11-29

Publication	Publication Date	Title
BRPI0307673A2 (pt)	2016-11-08	métodos de tratar doença vascular.
DE60023043D1 (de)	2006-02-16	(S,S)-Reboxetin zur Behandlung von Inkontinenz
EA200300025A1 (ru)	2003-06-26	Способ лечения патологического синдрома и лекарственное средство
FIU20060389U0 (fi)	2006-09-22	Luusairauksien hoito
EA200701175A1 (ru)	2008-02-28	Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний
NO20014769L (no)	2001-11-29	Preparat for behandling og diagnostikk av brystcancer og fremgangsmater for anvendelse derav
AU2002323258A1 (en)	2003-03-03	Diagnosis and treatment of vascular disease
AU2002367535A8 (en)	2003-11-03	Diagnosis and treatment of vascular disease
CY1112184T1 (el)	2015-12-09	Πυριδοξαμινη για χρηση στην αγωγη της διαβητικης nεφροπαθειας στο διαβητη τυπου ii
NO20026008D0 (no)	2002-12-13	Fremgangsmåte for behandling av cardiovaskul¶re sykdommer
DE50211137D1 (de)	2007-12-13	Seitenkettenhalogenierte aminodicarbonsaurederivate als arzneimittel zur behandlung von herz-kreislauf-erkrankungen
DE60027209D1 (de)	2006-05-18	Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
DE50201780D1 (de)	2005-01-20	Halogensubstituierte aminodicarbonsäurederivate als arzneimittel zur behandlung von herz-kreislauf-erkrankungen
DE50010284D1 (de)	2005-06-16	Arzneimittel zur behandlung von bluthochdruck
DE50013843D1 (de)	2007-01-18	Arzneimittel zur behandlung von darmerkrankungen
DK1417189T3 (da)	2006-05-08	Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
NO20020156L (no)	2002-03-15	Titanavledede forbindelser, fremstilling og anvendelse derav
NO20023526D0 (no)	2002-07-24	Kalsium-dikarboksylatetere, fremgangsmåter for fremstilling derav, og behandling av vaskul¶r sykdom og diabetes
IS2641B (is)	2010-08-15	3-Fenýl setið pýridóindólón, framleiðsla og meðferðarleg notkun þess.
DE60016047D1 (de)	2004-12-23	Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
DE60220220D1 (de)	2007-07-05	Blutbehandlungssystem
DE60223707D1 (de)	2008-01-03	Calcium-l-threonat zur behandlung von knochenfrakturen
EA200200853A1 (ru)	2003-02-27	Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
NO20033120L (no)	2003-09-11	2-arylimino-2,3-dihydrotiazolderivater, fremgangsmåter for fremstilling derav og terapeutisk anvendelse derav
DE60311822D1 (de)	2007-03-29	Neue piperazinyl-pyrazinon-derivate zur behandlung von 5-ht2a rezeptor-bedingten erkrankungen

Legal Events

Date	Code	Title	Description
2005-09-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application